Médicos proponen tratar la obesidad antes que las enfermedades crónicasnews2024-06-22T09:03:56+00:00June 22nd, 2024|The New York Times|
South Africa Runs Out of Insulin Pens as Global Supply Shifts to Weight-Loss Drugsnews2024-06-19T09:02:12+00:00June 19th, 2024|The New York Times|
Doctors Test the Limits of What Obesity Drugs Can Fixnews2024-06-18T09:13:35+00:00June 18th, 2024|The New York Times|
How Ozempic Is Transforming a Small Danish Townnews2024-04-20T04:01:50+00:00April 20th, 2024|The New York Times|
Inside Novo Nordisk, the Company Behind Ozempic and Wegovynews2024-04-20T04:01:23+00:00April 20th, 2024|The New York Times|
6 Reasons That It’s Hard to Get Your Wegovy and Other Weight-Loss Prescriptionsnews2024-02-02T20:20:57+00:00February 2nd, 2024|The New York Times|
Buried in Wegovy Costs, North Carolina Will Stop Paying for Obesity Drugsnews2024-01-26T18:52:40+00:00January 26th, 2024|The New York Times|
F.D.A. Approves New Obesity Drug Tirzepatide That Will Compete With Wegovynews2023-11-09T01:02:09+00:00November 9th, 2023|The New York Times|
Los medicamentos cotra la obesidad tienen sobreprecio, pero esto puede cambiarnews2023-10-26T09:02:55+00:00October 26th, 2023|The New York Times|
How Much Do Ozempic and Wegovy Cost? Not What You Think.news2023-10-22T07:00:20+00:00October 22nd, 2023|The New York Times|
